Q-State Biosciences Announces Presentation at the World Orphan Drug Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug 24, 2021--
Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of epilepsy, pain, and other disorders of the central nervous system, today announced that Chief Scientific Officer, Graham Dempsey, PhD, will be giving an oral presentation at the upcoming 2021 World Orphan Drug Congress USA to be held August 25-27 in Oxen Hill, Maryland.
The presentation will detail the company’s fully integrated platform that enables ultra-large scale, high-quality data generation for unique, artificial intelligence/machine learning-driven insights into diseases of the central nervous system (CNS).
Presentation details are as follows:
Technology-enabled Drug Discovery Platform using Patient-derived Neuronal Models, High-throughput Optogenetics and Machine Learning
Session Date and Time:
August 25, 2021, 1:40 PM ET
About Q-State Biosciences
Q-State Biosciences is a discovery technology and therapeutics company that applies a proprietary multi-discipline platform to discover genetically targeted therapeutics for epilepsy, pain, and other disorders of the CNS. By integrating advanced human neuronal models, custom determinative measurement engineering and powerful AI/machine learning, we unlock unique insights into the biological complexity of the brain, its associated disease states and the creation of transformational medicines. For more information, please visit www.qstatebio.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210824005795/en/
CONTACT: Business Development
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HEALTH CLINICAL TRIALS OTHER HEALTH
SOURCE: Q-State Biosciences
Copyright Business Wire 2021.
PUB: 08/24/2021 03:06 PM/DISC: 08/24/2021 03:06 PM